Howe & Rusling Inc Denali Therapeutics Inc. Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$16.01 - $28.82 $2,001 - $3,602	-125 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$14.2 - $27.98 $85 - $167	-6 Reduced 4.58%	125 $2,000
Q2 2019 Aug 12, 2019	SELL	$18.5 - $28.14 $111 - $168	-6 Reduced 4.38%	131 $3,000
Q1 2019 Apr 29, 2019	BUY	$17.99 - $24.65 $1,277 - $1,750	71 Added 107.58%	137 $3,000
Q4 2018 Feb 04, 2019	BUY	$13.88 - $21.75 $916 - $1,435	66 New	66 $1,000

228

120M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.